These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26985319)

  • 1. Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo.
    Dowling JE; Alimzhanov M; Bao L; Chuaqui C; Denz CR; Jenkins E; Larsen NA; Lyne PD; Pontz T; Ye Q; Holdgate GA; Snow L; O'Connell N; Ferguson AD
    ACS Med Chem Lett; 2016 Mar; 7(3):300-5. PubMed ID: 26985319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology.
    Johannes JW; Almeida L; Barlaam B; Boriack-Sjodin PA; Casella R; Croft RA; Dishington AP; Gingipalli L; Gu C; Hawkins JL; Holmes JL; Howard T; Huang J; Ioannidis S; Kazmirski S; Lamb ML; McGuire TM; Moore JE; Ogg D; Patel A; Pike KG; Pontz T; Robb GR; Su N; Wang H; Wu X; Zhang HJ; Zhang Y; Zheng X; Wang T
    ACS Med Chem Lett; 2015 Mar; 6(3):254-9. PubMed ID: 25815142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CK2 controls the recruitment of Wnt regulators to target genes in vivo.
    Wang S; Jones KA
    Curr Biol; 2006 Nov; 16(22):2239-44. PubMed ID: 17113388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
    Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
    Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK2 as a positive regulator of Wnt signalling and tumourigenesis.
    Seldin DC; Landesman-Bollag E; Farago M; Currier N; Lou D; Dominguez I
    Mol Cell Biochem; 2005 Jun; 274(1-2):63-7. PubMed ID: 16342409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production.
    Yefi R; Ponce DP; Niechi I; Silva E; Cabello P; Rodriguez DA; Marcelain K; Armisen R; Quest AF; Tapia JC
    J Cell Biochem; 2011 Nov; 112(11):3167-75. PubMed ID: 21732411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.
    Lee E; Salic A; Krüger R; Heinrich R; Kirschner MW
    PLoS Biol; 2003 Oct; 1(1):E10. PubMed ID: 14551908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin.
    Gillis WQ; Kirmizitas A; Iwasaki Y; Ki DH; Wyrick JM; Thomsen GH
    Cell Commun Signal; 2016 Aug; 14(1):15. PubMed ID: 27484226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
    Schmitz Y; Rateitschak K; Wolkenhauer O
    Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M.
    Kundu A; Khouri MG; Aryana S; Firestone GL
    Carcinogenesis; 2017 Dec; 38(12):1207-1217. PubMed ID: 29028954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase CK2 is required for Wntless internalization and Wnt secretion.
    de Groot RE; Rappel SB; Lorenowicz MJ; Korswagen HC
    Cell Signal; 2014 Dec; 26(12):2601-5. PubMed ID: 25178265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer.
    Dupasquier S; Blache P; Picque Lasorsa L; Zhao H; Abraham JD; Haigh JJ; Ychou M; Prévostel C
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
    PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Wnt/β-catenin signaling by p38 MAP kinase inhibitors is explained by cross-reactivity with casein kinase Iδ/ɛ.
    Verkaar F; van der Doelen AA; Smits JF; Blankesteijn WM; Zaman GJ
    Chem Biol; 2011 Apr; 18(4):485-94. PubMed ID: 21513885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.
    Dominguez-Brauer C; Khatun R; Elia AJ; Thu KL; Ramachandran P; Baniasadi SP; Hao Z; Jones LD; Haight J; Sheng Y; Mak TW
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1148-E1157. PubMed ID: 28137882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.